<DOC>
	<DOCNO>NCT01136980</DOCNO>
	<brief_summary>The objective study evaluate relative merit , safety effectiveness EsophyX transoral device perform advanced TIF procedure patient `` troublesome symptom '' define Montreal consensus definition PPIs compare sham placebo control .</brief_summary>
	<brief_title>Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial : The RESPECT Study</brief_title>
	<detailed_description>Primary Effectiveness Endpoint : A clinically significant reduction GERD symptom , specifically `` Troublesome '' regurgitation without heartburn assess Reflux Disease Questionnaire ( RDQ ) . Troublesome symptom occur minimum 2 day week least moderate severity . Secondary Effectiveness Endpoint : The normalization esophageal acid exposure 6 month clinically significant reduction PPI usage 12 month .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Hernia , Hiatal</mesh_term>
	<criteria>Age 1880 year Dependent upon daily PPIs &gt; 6 month Troublesome symptom , specifically heartburn regurgitation , 40 mg omeprazole equivalent . Troublesome heartburn regurgitation symptom occur minimum 23 day week least moderate severity . Abnormal ambulatory pH study PPI therapy 7 day . Normal near normal esophageal motility ( manometry ) Hiatal hernia axial height large 2 cm transverse dimension exceed 2.5 cm Patient willing cooperate postoperative dietary recommendation assessment test Signed informed consent BMI &gt; 35 Hiatal hernia &gt; 2 cm Esophagitis Los Angeles grade C D Esophageal ulcer Esophageal stricture Esophageal motility disorder Pregnancy plan pregnancy next 12 month ( female ) Immunosuppression ASA &gt; 2 Portal hypertension and/or varix History previous resective gastric esophageal surgery , cervical spine fusion , Zenker 's diverticulum , esophageal epiphrenic diverticulum , achalasia , scleroderma dermatomyositis , eosinophilic esophagitis , cirrhosis Active gastroduodenal ulcer disease Gastric outlet obstruction stenosis Severe gastroparesis delay gastric emptying confirm solidphase gastric empty study patient complain postprandial satiety assessment Coagulation disorder Interprocedural determination anatomical presentation opinion surgeon allow safe device introduction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>GERD</keyword>
	<keyword>Esophagitis</keyword>
	<keyword>Fundoplication</keyword>
	<keyword>Anti-reflux surgery</keyword>
	<keyword>PPI dependent</keyword>
</DOC>